Global Retinal Surgery Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Vitrectomy Machines, Vitrectomy Packs, Surgical Instruments, Microscopic Illumination Equipment, Retinal Laser Equipment, and Others), By Application (Clinical, Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Retinal Surgery Devices Market Insights Forecasts to 2035

• The Global Retinal Surgery Devices Market Size Was Estimated at USD 2.95 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.56% from 2025 to 2035
• The Worldwide Retinal Surgery Devices Market Size is Expected to Reach USD 8.05 Billion by 2035
• Asia Pacific is expected to Grow the fastest during the forecast period.

According to a Research Report Published by Spherical Insights and Consulting, The Global Retinal Surgery Devices Market Size was valued at approximately USD 2.95 Billion in 2024 and is projected to Grow from USD 3.23 Billion in 2025 to around USD 8.05 Billion by 2035 with a compound annual growth rate (CAGR) of 9.56% from 2025 to 2035. The factors driving the market's growth include rising rates of eye disorders, increasing use of minimally invasive surgical equipment, technological developments, growing awareness, expanding treatment options, an ageing population, cost-effectiveness and efficiency, rising rates of diabetes, and rising healthcare spending in developing nations.

Global Retinal Surgery Devices Market Forecast and Revenue Outlook

• 2024 Market Size: USD 2.95 Billion
• 2035 Projected Market Size: USD 8.05 Billion
• CAGR (2025-2035): 9.56%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market        

Market Overview

The retinal surgery devices market includes specialised tools, equipment, and technologies that support cutting-edge surgical techniques and enhance patient outcomes in the field of ophthalmology. The need for retinal surgical instruments is growing at an unprecedented rate due to the increasing knowledge of ocular diseases and therapies that allow for early diagnosis and treatment. The ageing of the world's population is enhancing volume due to a great susceptibility to cataracts, glaucoma, and presbyopia. Technology continues to advance the safety and effectiveness of surgical outcomes applicable to instruments, including LED virtual retina displays and minimally invasive surgical devices. The advantages of minimally invasive surgery, such as decreased pain, faster recovery, and less scarring, further facilitate this change. Likewise, due to increased life expectancy trends worldwide, the demand for retinal surgical devices will continue to grow. In the short term, emerging markets, such as China and India, are expected to provide new opportunities for market growth. Technological developments that improve results and recovery, like robotic-assisted operations, AI integration, and retinal lasers, are propelling the market for retinal surgery devices. Demand is driven by an increase in ophthalmic treatments in emerging regions as well as the rising incidence of diseases such as diabetic retinopathy. To increase their competitiveness, major firms like Alcon, Carl Zeiss, and Bausch + Lomb grow through alliances, mergers, and strategic projects. 

Key Market Insights

• North America is expected to account for the largest share in the Retinal Surgery Devices Market during the forecast period.
• In terms of product, the vitrectomy packs segment is projected to lead the Retinal Surgery Devices Market throughout the forecast period
• In terms of application, the diabetic retinopathy segment captured the largest portion of the market

Retinal Surgery Devices Market Trends

• Increasing use of less invasive surgical methods that provide patients with less discomfort and a quicker recovery.
• Combining AI and machine learning to improve the accuracy of retinal surgery and diagnostics.
• High-definition imaging and robotic-assisted surgery are becoming more and more popular.
• Growth in the use of retinal lasers to treat diseases such as diabetic retinopathy.
• Growth in emerging markets due to increased ophthalmic operations and better healthcare infrastructure.

Report Coverage

This research report categorizes the retinal surgery devices market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the retinal surgery devices market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the retinal surgery devices market.

Driving factors:

Rising eye disorder prevalence, a growing geriatric population with age-related vision loss, and increasing diabetes incidence are key factors driving the retinal surgery devices market.

The market for retinal surgery devices is being propelled by the increasing prevalence of vision-related diseases such as macular degeneration, retinitis pigmentosa, and diabetic retinopathy, particularly among elderly and diabetic populations. Adoption is being supported by increasing preference for advanced, precise, and affordable therapies. The increased ageing population, whose members are more prone to age-related eye diseases, further supports the market growth. Additionally, the market expansion is being driven by improvements in technology in minimally invasive surgical instruments, which enable safer and quicker recoveries. In conclusion, these factors, combined with an increase in the worldwide number of individuals with diabetes, fuel market growth.

Restraining Factor:

The market for retinal surgery devices is being held back by high costs, reimbursement issues, complicated procedures, and a lack of adequate healthcare infrastructure.

Market barriers for retinal surgery technologies include exorbitant gadget prices, restricted availability in low-income areas, and difficulties with reimbursement. Additional obstacles include the cost of training and the intricacy of retinal treatments. In addition, despite developments that improve surgical results and gadget use, adoption is constrained by inadequate specialised training programs and healthcare infrastructure in underdeveloped nations, which slows market penetration.

Market Segmentation 

The global Retinal Surgery Devices market is divided into product and application.

Global Retinal Surgery Devices Market, By Product:

Why is the vitrectomy packs segment expected to generate the highest revenue in 2024 for the global Retinal Surgery Devices market during the forecast period?

The vitrectomy packs segment in the retinal surgery devices market is expected to grow at the highest CAGR over the forecast period. Vitrectomy packs include all of the tools needed for the operation in a single box, which is already assembled, making retinal surgery procedures easier to complete. This provides more surgical efficiency and reduces the chances of forgetting instruments. In addition, and perhaps most importantly, it saves considerable time on preparation. They are gaining popularity among ophthalmic surgeons due to their cost, ease of use, and ability to promote strong workflows.

The retinal laser equipment segment in the retinal surgery devices market is expected to grow at the fastest CAGR over the forecast period. It is accurate, efficient, and adaptable. With the use of retinal laser equipment, surgeons can more accurately target particular regions of the retina, reducing tissue damage and enhancing therapeutic results. Numerous retinal disorders, including diabetic retinopathy, retinal tears, and macular degeneration, have been found to respond well to the use of retinal laser technology. The market is growing because of technological improvements, growing applications in ophthalmic surgeries, and rising demand for minimally invasive procedures.

Global Retinal Surgery Devices Market, By Application:

What factors make the diabetic retinopathy segment dominate in terms of market share during the forecast period in the global Retinal Surgery Devices market?

The diabetic retinopathy segment held the largest market share in the retinal surgery devices market. Diabetic retinopathy is one of the leading causes of blindness around the world. This condition affects the retina's blood vessels, leading to vision changes and possibly blindness. Diabetic retinopathy is a major concern in ophthalmology due to the prevalence of diabetes worldwide. Due to the effective treatment of diabetic retinopathy and early diagnosis of the condition with innovative surgical technology, the market is growing.

The epiretinal membrane segment in the retinal surgery devices market is expected to grow at the fastest CAGR over the forecast period. Visual impairment occurs due to an ERM, which is an abnormal fibrous tissue growth on the retina's surface. The increasing prevalence of diabetic retinopathy and age-related macular degeneration, both of which can lead to ERM, is the primary driver of market growth.

Regional Segment Analysis of the Global Retinal Surgery Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America Retinal Surgery Devices Market Trends

What factors contribute to the North America region holding the largest share of the global Retinal Surgery Devices market during the forecast period?

This is due to the region's skilled healthcare workforce, the high prevalence of disease, major market players, and technology advancements. In North America, there is an ample supply of ophthalmologists and other physicians with training in retinal procedures. There is likely to be acceptance when trained providers are present to use advanced surgical devices. Diabetic retinopathy is highly prevalent in North America, with increasing prevalence expected with rising cases of diabetes. The International Diabetes Federation estimates that by 2030, there will be 57 million adults in North America and the Caribbean with diabetes and 63 million by 2045.

Why does the United States lead the North American Retinal Surgery Devices market?

The high incidence of eye conditions such as age-related macular degeneration, diabetic retinopathy, and retinal detachments, the US leads the North American market for retinal surgery devices. The need for new retinal surgery equipment is being driven nationwide by factors such as advanced healthcare infrastructure, extensive access to ophthalmic care, high adoption of cutting-edge surgical technology, and substantial investment in research and development.

Asia Pacific Retinal Surgery Devices Market Trends

How is the Asia Pacific region expected to be the fastest-growing Retinal Surgery Devices market with the fastest growth rate? 

The retinal surgery devices market is anticipated to grow at the fastest rate in the Asia Pacific region. This expansion is the result of rising investments in healthcare facilities and infrastructure in developing nations like China and India. The region's residents may now obtain healthcare more easily and affordably thanks to government initiatives and investments in the field. Due to the country's high prevalence of age-related eye illnesses and growing elderly population, the market for retinal surgery devices in Japan is anticipated to expand rapidly over the next several years.

Why is the Retinal Surgery Devices market growing in Europe?

The European market for retinal surgery devices is focusing on specialised ophthalmic units and advanced healthcare systems that provide access to the most current surgical approaches and equipment. Timely surgical care is becoming more popular in the UK due to greater patient awareness of eye health, an uptick in routine eye examinations and their coverage, and more efficient treatment options. All of these factors are creating the sharp anticipated growth in demand for retinal surgery devices in the region going forward.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global retinal surgery devices market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Worldwide Top Key Players in The Retinal Surgery Devices Market Include

• Alcon Management S. A.
• Bausch & Lomb Incorporated
• Carl Zeiss
• Ellex Medical Lasers
• Erbe Elektromedizin
• Escalon Medicals
• Iridex Corporation
• Leica Microsystems GmbH
• Lumenis
• Nidek Co. Ltd.
• Optos PLC
• Second Sigh Medical Products
• Others 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent development

• In May 2025, the sophisticated OCT and ultra-widefield retinal imaging system MonacoPro was introduced by Optos. In an effort to improve diagnostic accuracy and expedite eye care procedures, it built upon the original Monaco by providing improved OCT picture quality, a larger reference library, and the new AreaAssist tool for workflow efficiency.
• In January 2025, Norlase's LYNX, a fully integrated pattern scanning laser indirect ophthalmoscope, was granted FDA 510(k) clearance and the CE Mark. With voice activation, sophisticated laser patterns, and wireless controls, LYNX, a device designed for retina treatments, improved portability, efficiency, and precision.
• In July 2024, Belkin Vision will be acquired by Alcon Inc. Direct selective laser trabeculoplasty (SLT) seeks to broaden the range of treatments available for glaucoma. SLT was found to be a clinically useful and economical treatment for ocular hypertension and open-angle glaucoma.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the retinal surgery devices market based on the following segments:

Global Retinal Surgery Devices Market, By Product

• Vitrectomy Machine
• Vitrectomy Packs
• Surgical Instruments
• Microscopic Illumination Equipment
• Retinal Laser Equipment
• Others

Global Retinal Surgery Devices Market, By Application

• Clinical
• Diabetic Retinopathy
• Retinal Detachment
• Epiretinal Membrane
• Macular Hole
• Others

Global Retinal Surgery Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa